The Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- 5 April 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 111 (13) , 1713-1716
- https://doi.org/10.1161/01.cir.0000160005.90598.41
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Coxibs and Cardiovascular DiseaseNew England Journal of Medicine, 2004
- Failing the Public Health — Rofecoxib, Merck, and the FDANew England Journal of Medicine, 2004
- Cyclooxygenase Isoforms and Platelet Vessel Wall Interactions in the Apolipoprotein E Knockout Mouse Model of AtherosclerosisCirculation, 2003
- Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout miceJournal of the American College of Cardiology, 2003
- Cyclooxygenase-2 Promotes Early Atherosclerotic Lesion Formation in LDL Receptor–Deficient MiceCirculation, 2002
- No Effect of Cyclooxygenase Inhibition on Plaque Size in Atherosclerosis-prone MiceScandinavian Cardiovascular Journal, 2002
- Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout miceProceedings of the National Academy of Sciences, 2001
- Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet ActivationNew England Journal of Medicine, 1984
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976